Whole exome sequencing and fluorescence in situ hybridization (FISH) have identified FGFR2 alterations primarily in 6%-50% of ICC and 0-5% of ECC [28–31, 59, 60]. This evidence concerns the gene FGFR2 and intrahepatic cholangiocarcinoma.